Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer
J Thorac Dis
.
2018 Sep;10(Suppl 26):S3186-S3191.
doi: 10.21037/jtd.2018.08.25.
Authors
Qianping Li
1
2
,
Weijie Ma
2
,
Tianhong Li
2
3
Affiliations
1
Department of Cardiothoracic Surgery, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai 200233, China.
2
Division of Hematology/Oncology, Department of Internal Medicine, University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
3
Veterans Affairs Northern California Health Care System, Mather, CA, USA.
PMID:
30430029
PMCID:
PMC6186589
DOI:
10.21037/jtd.2018.08.25
No abstract available
Publication types
Editorial
Comment